Endogenous Vascular Hydrogen Peroxide Regulates Arteriolar Tension In Vivo
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Background-Although many studies suggested direct vasomotor effects of hydrogen peroxide (H 2 O 2 ) in vitro, little is known about the vasomotor effects of H 2 O 2 in vivo. Methods and Results-We have generated mice overexpressing human catalase driven by the Tie-2 promoter to specifically target this transgene to the vascular tissue. Vessels of these mice (cat ϩϩ ) expressed significantly higher levels of catalase mRNA, protein, and activity. The overexpression was selective for vascular tissue, as evidenced by immunohistochemistry in specimens of aorta, heart, lung, and kidney. Quantification of reactive oxygen species by fluorescence signals in cat ϩϩ versus catalase-negative (cat n ) mice showed a strong decrease in aortic endothelium and left ventricular myocardium but not in leukocytes. Awake male cat ϩϩ at 3 to 4 months of age had a significantly lower systolic blood pressure (sBP, 102.7Ϯ2.2 mm Hg, nϭ10) compared with their transgene-negative littermates (cat n , 115.6Ϯ2.5 mm Hg, Pϭ0.0211) and C57BL/6 mice (118.4Ϯ3.06 mm Hg, nϭ6). Treatment with the catalase inhibitor aminotriazole increased sBP of cat ϩϩ to 117.3Ϯ4.3 mm Hg (Pϭ0.0345), while having no effect in cat n (118.4Ϯ2.4 mm Hg, nϭ4, PϾ0.05). In contrast, treatment with the NO-synthase inhibitor nitro-L-arginine methyl ester (100 mg · kg BW Ϫ1 · d
Ϫ1
) increased sBP in cat ϩϩ and C57Bl/6 to a similar extent. Likewise, phosphorylation of vasodilator-stimulated phosphoprotein in skeletal muscle, left ventricular myocardium, and lung was identical in cat Key Words: hydrogen peroxide Ⅲ blood pressure Ⅲ catalase, vascular Ⅲ aminotriazole Ⅲ contractility H ydrogen peroxide is a nonradical reactive oxygen species that is produced in many different cell types in the human body, including vascular endothelial and smooth muscle cells. 1 A large number of reports during the past 20 years have suggested that hydrogen peroxide may be an important mediator in the vasculature, eg, a regulator of vasomotor tone. [2] [3] [4] However, in vitro studies have yielded conflicting results on the effect of hydrogen peroxide on vasomotor tone, 5, 6 suggesting that the vasomotor response to hydrogen peroxide depends on experimental conditions, such as the type of vessel studied, the species studied, and the concentration range used. For example, endothelial hydrogen peroxide has been shown to relax mouse and human mesenteric arteries 7, 8 but not human radial arteries. 9 The steady-state concentration of hydrogen peroxide in human plasma, blood cells, and vascular cells is unknown but is most likely in the lower micromolar range or less. 1 In
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contrast, the vast majority of studies investigated the vasomotor effects of exogenous hydrogen peroxide at much larger concentrations (up to 10 mmol/L), and both vasodilator and vasoconstrictor effects were reported. [3] [4] [5] 10 Vasodilator effects of hydrogen peroxide may be mediated by activation of K ϩ channels, 7 activation of endothelial NO production, 11, 12 decreased myosin phosphorylation, 13 and inhibition of myosin ATPase, 14 whereas vasoconstriction is attributed to an increase of intracellular Ca 2ϩ , 15 to the generation of arachidonic acid metabolites with vasoconstrictor activity, 16 and to direct Ca 2ϩ -independent tonic effects on the smooth muscle contractile apparatus. 17, 18 Recent studies in mouse and rat mesenteric arteries and mouse aorta showed vasoconstrictor effects at up to 10 mol/L of hydrogen peroxide, whereas higher concentrations induced sustained and almost irreversible vasodilation. 16, 19 These data suggest a biphasic action of hydrogen peroxide on the vasomotor tone of conductance and small mesenteric arteries, in which lower micromolar concentrations induce predominantly vasoconstrictor effects. Although there are no data on the effects of hydrogen peroxide on the vascular tone of small skeletal muscle resistance arteries, it seems possible that the vasomotor effects of endogenously produced hydrogen peroxide contribute to the regulation of blood pressure. In hypertension, the plasma concentration of hydrogen peroxide is increased and is positively correlated to plasma renin activity and systolic blood pressure (sBP) but negatively correlated to cardiac contractility and renal function. 20 To investigate the effects of endogenous vascular hydrogen peroxide on small skeletal resistance vessels in vivo, we studied a transgenic mouse with a vascular-specific overexpression of human catalase.
Methods

Generation of Transgenic Mice
We generated a transgenic construct in which human catalase (hCat) was inserted between murine Tie-2 Promotor (2.1 kb) and a 10-kb Tie-2 intron fragment, designated as Tie-2 enhancer, and this construct was used to target catalase gene expression to the vasculature as described previously. 21 Founder mice showing approximately 100-fold higher catalase expression were crossed 10 times to C57BL/6 mice to generate pure C57BL/6 background (cat ϩϩ ). Mice were used at 12 to 16 weeks of age. Transgene-negative littermates (cat n ) served as controls. In addition, C57BL6 mice were used as nontransgenic controls. In some experiments, mice carrying a vascular-specific overexpression of wild-type endothelial nitric oxide synthase (eNOS) driven by the murine Tie-2 promotor were used. Vascular overexpression of eNOS (eNOS ϩϩ ) was evident by a 1.66Ϯ0.13-fold eNOS protein content in the aorta (nϭ5, PϽ0.05) compared with transgene negative littermates (eNOS n ). 
Ethical Statement
Preparation of 100g Supernatants
To prepare protein homogenates, mouse thoracic aortas were flashfrozen in liquid nitrogen, homogenized, solubilized in lysis buffer (50 mmol/L Tris-HCl, 1 mmol/L DTT, 1 mol/L proteinase inhibitors), and centrifuged 10 minutes at 100g. Supernatants were stored at Ϫ70°C until used for Western blots.
Western Blotting
Western blot analysis was performed in a blinded manner, as described previously, 22 using commercially available monoclonal antibodies directed against eNOS (Transduction Laboratories), rabbit antiserum M4 against vasodilator-stimulated protein (VASP, Alexis), monoclonal anti-phospho-Ser239 antibody 16C2 (Vasopharm), and a polyclonal antibody for catalase (Calbiochem) as well. Blots were developed by use of enhanced chemiluminescence (Roche) and exposed to x-ray film. The autoradiographs were analyzed by densitometry (Geldoc, Bio-Rad). Total protein levels were determined by the Bradford method. 23 
Immunohistochemistry
Different organs of the mice (heart, aorta, lung, kidney) were removed, immediately fixed in Bouin's fluid, and embedded in paraffin wax. Sections 8 m thick were stained for catalase (antibody diluted 1:100, anti-human, from rabbit; Calbiochem). After incubation for 60 minutes at room temperature, the reaction was detected by an ABC system (Vector Elite Kit) using biotinylated second antibodies and PO-conjugated streptavidin. Before the reaction, all sections were digested for 30 minutes with 0.1% trypsin.
Smooth Muscle Layer Thickness
Aortic rings (1 cm long) of cat ϩϩ and cat n were fixed in buffered 4% formalin and embedded ethanol-free in the water-soluble plastic resin Technovit 7100 (Heraeus-Kulzer) to prevent shrinkage and lipid extraction. Sections 4 m thick were stained with 1% toluidine blue, and intima-media thickness was measured by use of the image analyzing system CUE-3 (Olympus Ltd, version 4.5, 1993) . The measurements were routinely performed in a double-blind experimental approach by a technical assistant who had no knowledge of the specific scientific background of the study.
Detection of Reactive Oxygen Species
The hydrogen peroxide level was monitored with 5-and 6-carboxy-2Ј7Ј-dichlorodihydrofluorescein diacetate bis(acetomethyl)ester (DCDHF-DA, Molecular Probes), which can be oxidized to the fluorescent compound 2Ј7Ј-dichlorofluorescein. 24 The intimal layer of longitudinally cut mouse aortic rings was incubated with 5 mol/L DCDHF-DA for 30 minutes at 37°C and rinsed 3 times with PBS, and fluorescence was visualized on a Leica TCS SP2 confocal microscope (excitation, 488 nm; emission, 525 nm). Slices of left ventricle of cat ϩϩ and cat n mice were pretreated for 1 hour at 37°C with vehicle or with the catalase inhibitor aminotriazole (1 mmol/L), followed by incubation with 5 mol/L DCDHF-DA. and quantification of fluorescence intensity. In addition, the basal level of oxidative stress was measured in leukocytes by means of dihydroethidine fluorescence intensity as analyzed by fluorescence-activated cell sorter (FACS). 25 
Measurement of Blood Pressure and Heart Rate
SBP and heart rate were measured in awake male cat ϩϩ (nϭ8), cat n (nϭ8), and C57Bl/6 mice (nϭ6) at 3 to 4 months of age using an automated tail-cuff system (Visitech Systems) as described previously. 26 In some experiments, cat ϩϩ and cat n mice (nϭ4 each) were treated with aminotriazole (666 mg · kg Ϫ1 · d Ϫ1 , dissolved in drinking water) for 14 days. In another subset of experiments, cat ϩϩ (nϭ6) and C57Bl/6 (nϭ5) mice were treated for 28 days with N -nitro-Larginine (100 mg · kg BW Ϫ1 · d Ϫ1 ), and blood pressure and heart rate were recorded before, during, and after the treatment period.
Organ Bath Experiments
Preparation of thoracic ring segments was performed in HEPEScontaining Krebs-Henseleit buffer, and the organ bath experiments were performed in the same buffer lacking HEPES. After a 60-minute equilibration period, aortic rings were repeatedly subjected to 80 mmol/L KCl. The vasoconstriction that developed during the last of 3 KCl applications was taken as the maximal receptorindependent vasoconstriction. The function of the endothelium was examined by cumulative addition of acetylcholine (1 nmol/L-10 mol/L) after submaximal precontraction with phenylephrine. In cat ϩϩ (nϭ4) and cat n (nϭ4) mice, endothelium-dependent vasodilation to the NO donor DEA-NO (0.1 nmol/L-10 mol/L) was followed by a cumulative application of phenylephrine (1 nmol/L-10 mol/L). Thereafter, the aortic rings were incubated for 30 minutes with aminotriazole (1 mmol/L) or vehicle, and a concentrationresponse curve for phenylephrine (1 nmol/L-10 mol/L) was performed. Reaction to increasing concentrations of hydrogen peroxide (10 nmol/L-10 mmol/L) was examined in endothelium-intact or denuded aortic segments of cat ϩϩ and cat n /C57BL/6 mice after precontraction with phenylephrine (0.1 mol/L).
Substances and Solutions
All chemicals were obtained from Merck or from Sigma in analytical grade. Stock solutions were prepared daily, diluted with Krebs-buffer as required, kept on ice, and protected from daylight until use. All 
Statistics
All data were analyzed by standard computer programs (GraphPad Prism PC Software, Version 3.0, ANOVA) and are expressed as mean values and SEM. Significant differences were evaluated by use of either the Newman-Keuls multiple comparison test after 1-way ANOVA, 2-way ANOVA, or Student t test. A probability value of less than 0.05 was considered significant.
Results
Characterization of Catalase Overexpression
Injection of the catalase-Tie-2-promotor construct resulted in a marked overexpression of catalase, as evidenced by Southern blot in the myocardium (not shown), competitive reverse transcription-polymerase chain reaction (31.7Ϯ4. 2 .05) in the aorta, the lung, and the heart. Immunohistochemistry performed in cross sections of the aorta, the heart, the lung, and the kidney of cat ϩϩ showed that the overexpression occurred specifically in blood vessels (Figure 1 ). Examination of the steady-state content of hydrogen peroxide in endothelial cells by confocal microscopy using longitudinally cut aortic segments pretreated with DCDHF-DA revealed a significant reduction of the fluorescence signal in cat ϩϩ (1973Ϯ244) compared with cat n (3808Ϯ664, nϭ8, Pϭ0.0021). Likewise, DCDHF-DA-induced fluorescence was much smaller in slices of left ventricular myocardium of cat ϩϩ compared with cat n , whereas this difference disappeared in the presence of aminotriazole, which increased the fluorescence signal to the same degree in mice of both strains ( Figure 2) . In striking contrast, oxidative stress in leukocytes as measured by dihydroethidine fluorescence using FACS analysis was not different in cat n (43Ϯ6 U, nϭ10) and cat ϩϩ (44Ϯ8 U, nϭ9) but increased strikingly in cat ϩϩ treated with aminotriazole (107Ϯ5, nϭ5). These data indicate that cat ϩϩ mice specifically overexpress catalytically active catalase protein in vascular cells.
Smooth Muscle Layer Thickness
To evaluate a possible effect of catalase overexpression on the media thickness of the vasculature, we measured the smooth muscle layer thickness of different arteries. Figure 3A) . Catalase overexpression had no effect on heart rate (data not shown). The decrease of sBP in cat ϩϩ was identical to that in eNOS ϩϩ mice (105.3Ϯ2.6 mm Hg, nϭ6, Figure 3B ). These data indicate that overexpression of catalase causes the same degree of sBP reduction as overexpression of eNOS.
Aminotriazole Treatment
Treatment of cat ϩϩ (nϭ4) and cat n (nϭ4) with the catalase inhibitor aminotriazole significantly raised sBP in cat ϩϩ mice, whereas it had little effect on the sBP of cat n ( Figure 3C ). There was no change of heart rate caused by inhibition of catalase (data not shown). The recovery of sBP by aminotriazole treatment suggests that the reduction of blood pressure in cat ϩϩ mice is caused by overexpression of catalase and a subsequent decrease of the vascular hydrogen peroxide steady-state concentration.
Aortic eNOS Expression
To evaluate a possible effect of catalase overexpression on vascular eNOS expression, we compared aortic eNOS protein levels in cat n and cat ϩϩ . As shown in Figure 4 , overexpression 
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of catalase had no effect on aortic eNOS protein content. In contrast, Western blot analysis in eNOS ϩϩ mice demonstrated a significantly elevated aortic eNOS protein level of 166Ϯ13.7% (nϭ5, PϽ0.05, Figure 4 ). These findings indicate that the reduction of sBP in cat ϩϩ mice is not caused by an increase of aortic eNOS protein expression.
NO Bioavailability
To evaluate whether overexpression of catalase changes the bioavailability of endogenous NO, C57BL/6 and cat ϩϩ mice were treated with the NO synthase inhibitor N G -nitro-Larginine methyl ester (L-NAME) for 6 weeks. As expected, L-NAME elevated blood pressure significantly in C57BL/6 mice, from 118Ϯ3 to 146Ϯ5.6 mm Hg (nϭ6, PϽ0.001, Figure 5A ). This 23.3Ϯ4.8% increase of sBP observed in C57BL/6 mice was almost identical to the 20.3Ϯ2.8% increase of sBP in cat ϩϩ ( Figure 5B ), in which an elevation from 103Ϯ2.3 to 125Ϯ4.5 mm Hg occurred (nϭ6, PϽ0.001). In both mouse strains, termination of L-NAME treatment induced a complete restoration of sBP to pretreatment values. We have also measured VASP phosphorylation to further substantiate that the NO/cGMP system is not involved. There was no change in the total VASP protein content in cat ϩϩ in the lung (120Ϯ12%, nϭ4), the skeletal muscle (92Ϯ10%, nϭ4), and the heart muscle (109Ϯ19%, nϭ3), tissues known to contain mostly resistance vessels. Likewise, phosphorylated VASP protein was also identical in cat n and cat ϩϩ , as indicated by the relative Western blot signal intensity in cat ϩϩ in the lung (117Ϯ36%, nϭ8), the skeletal muscle (126Ϯ20%, nϭ4), and the heart (95Ϯ29%, nϭ4).
Studies of Isolated Aortic Segments
Aortic responses to increasing concentrations of acetylcholine ( Figure 6A ) were similar in cat ϩϩ and cat n , confirming that the bioavailability of endothelial NO is not altered by a reduction of vascular hydrogen peroxide levels. Likewise, the efficiency of the NO/cGMP pathway remained in cat ϩϩ , as evidenced by aortic responses to the spontaneous NO donor DEA-NO ( Figure 6B ). Thus, vascular overexpression of catalase had no effect on endothelium-dependent and -independent NO-mediated relaxation of conductance vessels.
Subjection of aortic rings to a single dose of 80 mmol/L KCl induced a strong vasoconstriction in cat n (9.65Ϯ0.34 mN, nϭ4). Aortic rings of cat ϩϩ showed a significantly lower maximal response to 80 mmol/L KCl of 8.05Ϯ0.46 mN (nϭ4, Pϭ0.0322), although there was no change of the media thickness in this vessel type (see above). These data suggest that overexpression of catalase decreases the contractile response of vascular smooth muscle cells caused by depolarization. In contrast, concentration-dependent vasoconstriction to phenylephrine was similar in cat n and cat ϩϩ (Figure 7 ). Neither the half-maximal effective concentration given as pD 2 values in Ϫlog mol/L for phenylephrine in cat ϩϩ (6.46Ϯ0.2, nϭ4) and cat n (6.45Ϯ0.2, nϭ4) nor maximal vasoconstrictions to phenylephrine in cat ϩϩ (5.49Ϯ0.54 mN, nϭ4) and cat n (5.48Ϯ0.54 mN, nϭ4) were different. However, although inhibition of catalase with aminotriazole had only little effect on phenylephrine constrictions in cat ϩϩ , it significantly increased phenylephrine constrictions in cat n (Pϭ0.023, nϭ4, Figure 7 ), suggesting a contribution of endogenous hydrogen peroxide to adrenergic vasoconstriction in conductance vessels.
To investigate vasoconstrictor effects of exogenous hydrogen peroxide, denuded aortic rings of cat n and cat ϩϩ were subjected to increasing concentrations of hydrogen peroxide. Small vasoconstrictor effects were observed up to 50 mol/L hydrogen peroxide in cat n only, whereas higher concentrations induced strong and irreversible vasodilator effects in cat n and cat ϩϩ (Figure 8 ). After washout of vasodilator concentrations of hydrogen peroxide, aortic rings did not respond to KCl or phenylephrine any longer (data not shown).
Discussion
The aim of this study was to determine the effect of endogenous vascular hydrogen peroxide on the vasomotor tone of resistance vessels in vivo. Our new finding is that a reduction of steady-state concentrations of vascular hydrogen peroxide induced by a vascular specific overexpression of human catalase resulted in a marked reduction of sBP in mice. This hypotension was completely reversed by treatment with the catalase inhibitor aminotriazole but was independent of vascular eNOS protein content, eNOS activity, and the 
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efficiency of the NO/cGMP pathway as evidenced by Western blot analysis, chronic treatment with the NOS inhibitor L-NAME, and organ bath experiments, respectively. These data suggest that endogenous hydrogen peroxide is a vasoconstrictor in resistance vessels in vivo. We assume that the vasoconstrictor effects of hydrogen peroxide in resistance vessels might contribute to the development of essential hypertension. Our data obtained in transgenic mice overexpressing catalase strongly support the concept that reactive oxygen species, such as hydrogen peroxide, generated in the vascular wall can modulate arterial tone and are involved in the pathogenesis of such vascular diseases as hypertension. 27, 28 As predicted, 29 catalase overexpression driven by the Tie-2 promotor construct was vascular-specific in our mouse model. This was evident in the aorta, the lung, the heart, and the kidney. Vascular specificity was further investigated by measuring dihydroethidine fluorescence in leukocytes by FACS analysis, and no difference was found between cat n and cat ϩϩ , suggesting an absence of catalase overexpression in nonvascular cells, as found in a variety of organs. Our cat ϩϩ mouse is the first transgenic animal model in which a mammalian gene was overexpressed, driven by the Tie-2 promotor. In the original publication describing the discovery of the Tie-2 promotor, Schläger et al 29 suggested an endothelium-specific expression induced by this promotor. However, this was not directly proved by histology of cross sections of vascularized tissues, and our results rather suggest a vascularspecific instead of an endothelium-specific expression pattern induced by the Tie-2 promotor.
In our animal model, catalase overexpression was associated with a substantial reduction of blood pressure in resting awake mice, and this hypotension was completely reversible by the catalase inhibitor aminotriazole. Recently, Yang et al 30 reported that catalase-overexpressing mice generated by means of an 80-kb P1 clone containing the entire human catalase gene show no change of hydrogen peroxide release from the aorta and have normal blood pressure. Thus, specific targeting of catalase overexpression to the vasculature appears to be important to unmask a vasotonic effect of endogenous hydrogen peroxide.
It has been shown that vascular hydrogen peroxide has many associations with the vascular NO/cGMP pathway. 3, 4 For example, hydrogen peroxide may either enhance endogenous NO generation by increasing the activity and expression of eNOS 11, 12, 31 or impair endothelial production of NO in response to such mediators as the calcium ionophore A23187, bradykinin, and ADP. 32 Hydrogen peroxide might also play a role in flow-mediated vasodilation, and catalase most likely consumes NO, which partially inhibits the reaction of the enzyme with hydrogen peroxide. 33, 34 We investigated whether hypotension in cat ϩϩ is associated with changes of the vascular eNOS content or the bioavailability of endogenous NO. Aortic eNOS protein was not changed, suggesting that the reduction of vascular hydrogen peroxide in cat ϩϩ had no impact on the regulation of endothelial eNOS expression.
The lack of influence on eNOS expression of a reduced vascular hydrogen peroxide content probably results from the complex regulation of vascular eNOS expression, leaving a 
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lot of compensatory mechanisms. 35 We were also unable to detect differences of the bioavailability of vascular NO in resistance and conductance vessels. Oral treatment with the NOS inhibitor L-NAME induced an identical rise of sBP in cat ϩϩ and cat n , and the approximately 15-mm Hg difference in sBP remained. Likewise, aortic endothelium-dependent vasodilation in cat ϩϩ was normal, and measurement of serine-239 -VASP phosphorylation 36 showed a similar degree of activation of the NO/cGMP pathway in tissues known to contain mostly resistance vessels. These data do not support the hypothesis that endogenous hydrogen peroxide impairs endogenous NO production and bioavailability in BPregulating skeletal resistance vessels.
Previous data obtained in endothelium-denuded mouse and rat mesenteric arteries have suggested that concentrations of exogenous hydrogen peroxide (0.1 to 10 mol/L), which probably resemble in vivo conditions, induce either no response or a vasoconstriction. 16, 19 Such vasoconstrictor effects of hydrogen peroxide might be mediated by an increase of intracellular Ca 2ϩ , 15 the generation of arachidonic acid metabolites with vasoconstrictor activity, 16 and a direct Ca 2ϩ -independent tonic effect on the smooth muscle contractile apparatus. 17, 18 These in vitro vasocontractile activities of exogenous hydrogen peroxide might also occur in vivo and might explain hypotension in cat ϩϩ , which is dependent on catalase activity, as evidenced by the complete reversal after aminotriazole treatment. Inhibition of catalase activity by aminotriazole also unmasked a potentiation of adrenergic vasoconstriction by phenylephrine in aortic rings of cat n that was attenuated in cat ϩϩ , as expected. In addition, concentrations of hydrogen peroxide that most likely resemble in vivo conditions induced vasoconstrictor effects in aortic rings submaximally precontracted with phenylephrine. We suggest that the vasoconstrictor and/or calcium-sensitizing effect of hydrogen peroxide in vivo is already exploited at normal physiological concentrations that occur in the vascular wall. A further increase by treatment with aminotriazole does increase blood pressure slightly but not significantly. Likewise, aminotriazole did increase DCDHF-DA fluorescence of ventricular slices of cat n slightly but not significantly, while having a much stronger effect in cat ϩϩ . Vasoconstriction to phenylephrine is mediated by ␣ 1A/C receptors on vascular smooth muscle cells. 37 Activation of these G-protein-coupled receptors results in stimulation of different intracellular enzymes that are involved in the signal transduction. The second messengers 1,4,5-inositol triphosphate (IP 3 ) and diacyl glycerol are generated by phospholipase C. Whereas IP 3 releases calcium from the sarcoplasmic reticulum and thereby directly initiates vasoconstriction, diacyl glycerol activates protein kinase C and supports the intracellular calcium release. 38 Hydrogen peroxide is known to interact with some proteins of this signal transduction pathway, such as phospholipase C, protein kinase C, and phosphoinositide 3-kinase, which might explain the molecular mechanisms underlying hydrogen peroxide-induced increases of vascular tone. 39 It might be argued that aortic rings are not a suitable model to investigate the effects of hydrogen peroxide on resistance vessels. However, our data are consistent with the observed change of sBP, with the effects of aminotriazole in vivo and in vitro, and with a previous report showing that increases of blood pressure in response to vasoconstrictor agents such as norepinephrine and angiotensin II were less pronounced in mice with an unspecific overexpression of catalase. 30 Thus, the involvement of endogenous hydrogen peroxide in adrenergic constriction of resistance vessels in vivo most likely contributes to hypotension in cat ϩϩ . We found that aortic rings of cat ϩϩ had a significantly lower maximal vasoconstrictor response to KCl. KCl induces a depolarization of the smooth muscle cell membrane and a subsequent influx of calcium through L-type calcium channels. 40, 41 It has been shown that the increase of the intracel- lular calcium concentration induced by KCl is not accompanied by a calcium release from the sarcoplasmic reticulum. 42 This selective dependency of KCl-induced vasoconstrictions on the influx of extracellular calcium is widely used to initially evaluate the response of isolated vascular preparations to increased cytosolic calcium concentrations in smooth muscle cells. 40 Hence, our data suggest that the vascular calcium contraction coupling might be less efficient in cat ϩϩ . In mouse-tail arterioles, elevation in transmural pressure causes generation of reactive oxygen species, of which particularly hydrogen peroxide initiates myogenic constriction. 18 It is interesting to speculate on a causal role of hydrogen peroxide in the development of essential hypertension. Experimental as well as clinical hypertension is associated with oxidative stress. 27, 43 Furthermore, previous studies indicate that in hypertension, the plasma concentration of hydrogen peroxide is increased and is positively correlated to plasma renin activity and sBP but negatively correlated to cardiac contractility and renal function. 20 Still, it is not known whether vascular oxidative stress is a result of the disease or may be one underlying cause. Treatment options that have been shown to reduce vascular oxidative stress also reduce blood pressure. 27, 43 The direct demonstration of hypotension in mice carrying a vascular specific overexpression of catalase strongly argues for both direct vasoconstrictor effects of endogenous hydrogen peroxide on resistance vessels and a possible contribution of these effects to the development of hypertension.
One might consider limitations of our study on the basis of the fact that neither aminotriazole nor DCDHF-DA and dihydroethidine are entirely specific compounds. Unfortunately, there are no alternative chemical tools showing better specificity. 44 Although DCDHF-DA detects primarily hydrogen peroxide, it is also oxidized by superoxide, although to a much lesser extent. Likewise, dihydroethidine detects primarily superoxide but is also known to be oxidized by hydrogen peroxide. The DCDHF-DA signal was much lower in the Time-dependent changes of sBP (A) and heart rate (C) in cat ϩϩ (nϭ6) and C57Bl/6 (nϭ5) mice during (4 weeks) and after (2 weeks) L-NAME (100 mg · kg BW Ϫ1 · d Ϫ1 ) treatment. There was no effect of L-NAME application on the difference (in % from control level) in sBP (B) and heart rate (D) between C57Bl/6 and cat ϩϩ . Application (ϩ) and removal (Ϫ) of the NOS inhibitor L-NAME indicated by arrows. Figure 6 . Endothelium-dependent relaxation to acetylcholine (A) and NO-dependent vasodilation to NO donor DEA-NO (B) in aortic rings of cat ϩϩ and cat n mice. Overexpression of catalase had no influence on these vascular responses to acetylcholine (Pϭ0.75, nϭ4) and DEA-NO (Pϭ0.82, respectively, nϭ4).
aortic endothelium and the left ventricular myocardium in cat ϩϩ compared with cat n , and this was associated with (1) a 6-fold increase of catalase mRNA expression, (2) a 2-fold increase of catalase protein expression, (3) a 3-fold increase of catalase activity in these tissues 21 , and (4) a 2-fold increase of the DCDHF-DA signal after treatment with aminotriazole, leaving little room to explain the oxidation of the fluorescent dyes by superoxide. In vitro data suggest that aminotriazole might inhibit not only catalase but also glutathione peroxidase, but the latter does not seem to occur in cardiovascular tissue of mammals in vivo. 45 These data are consistent with our observation the aminotriazole strongly increased the blood pressure of cat ϩϩ but had only a small effect in cat n . However, we cannot completely rule out the possibility that aminotriazole slightly inhibited glutathione peroxidase in cardiovascular tissue of cat ϩϩ and cat n . 
